# Impact of Two Genetic Variants of OATP1B3 or MRP2 or Rifampin on Systemic Disposition and Biological Efficacy of CCK-8

> **NCT02507167** · PHASE1 · COMPLETED · sponsor: **University Medicine Greifswald** · enrollment: 19 (actual)

## Conditions studied

- Gastrointestinal Hormones

## Interventions

- **DIETARY_SUPPLEMENT:** mixed meal
- **DRUG:** Rifampin

## Key facts

- **NCT ID:** NCT02507167
- **Lead sponsor:** University Medicine Greifswald
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-07
- **Final completion:** 2014-12
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2015-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02507167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02507167, "Impact of Two Genetic Variants of OATP1B3 or MRP2 or Rifampin on Systemic Disposition and Biological Efficacy of CCK-8". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02507167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*